Document Type
Article
Publication Date
2016
Abstract
In this article, Professor Orentlicher explores free speech and federalism issues arising from FDA regulation of off-label uses and off-label marketing of drugs. In light of the FDA's desire to respect state government authority, together with other considerations discussed in this article, he argues for the rejection of the analysis of the Caronia court and to give the FDA significant leeway in its regulation of off-label marketing.
Publication Citation
50 Wash. U. J. L. & Pol'y 89 (2016).
Recommended Citation
Orentlicher, David, "Off-Label Drug Marketing, the First Amendment, and Federalism" (2016). Scholarly Works. 1037.
https://scholars.law.unlv.edu/facpub/1037
Included in
Constitutional Law Commons, Consumer Protection Law Commons, First Amendment Commons, Food and Drug Law Commons, Health Law and Policy Commons
